π 100% Cancer Remission:
A groundbreaking study has achieved a 100% cancer remission rate in all rectal cancer patients through a monoclonal antibody trial, as reported by Memorial Sloan Kettering (MSK) Cancer Center.
π 100% Cancer Remission:
A groundbreaking study has achieved a 100% cancer remission rate in all rectal cancer patients through a monoclonal antibody trial, as reported by Memorial Sloan Kettering (MSK) Cancer Center.